Bioventus Inc. (BVS)

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	369	415	203	1,090	-	-
Market Cap Growth	392.90%	104.55%	-81.39%	-	-	-
Enterprise Value	735	773	591	1,398	102	133
PE Ratio	-	-2.66	-1.28	56.26	-	-
PS Ratio	0.71	0.81	0.40	2.53	-	-
PB Ratio	2.15	2.39	0.62	2.38	-	-
P/FCF Ratio	133.86	52.00	-8.61	115.09	-	-
P/OCF Ratio	53.87	27.05	-14.99	47.41	-	-
EV/Sales Ratio	1.41	1.51	1.15	3.25	0.32	0.39
EV/EBITDA Ratio	10.00	-13.30	-4.35	26.19	1.81	2.21
EV/EBIT Ratio	35.32	-6.69	-3.09	75.51	3.71	4.45
EV/FCF Ratio	266.69	96.83	-25.06	147.66	1.84	3.48
Debt / Equity Ratio	2.28	2.27	1.29	0.78	1.31	1.38
Debt / EBITDA Ratio	5.32	-6.80	-3.08	6.70	3.36	3.28
Debt / FCF Ratio	141.96	49.47	-17.73	37.77	3.41	5.16
Quick Ratio	0.87	0.91	0.55	0.96	1.43	1.68
Current Ratio	1.53	1.53	0.90	1.46	1.73	2.06
Asset Turnover	0.64	0.61	0.40	0.54	0.66	0.74
Interest Coverage	0.50	-2.84	-15.89	16.66	2.81	1.39
Return on Equity (ROE)	-12.30%	-86.50%	-40.50%	8.70%	11.40%	4.80%
Return on Assets (ROA)	-2.70%	-18.70%	-12.30%	2.40%	3.40%	1.50%
Return on Capital (ROIC)	-4.50%	-21.18%	-25.28%	1.41%	4.46%	2.31%
Earnings Yield	-5.87%	-37.64%	-78.22%	1.78%	-	-
FCF Yield	0.75%	1.92%	-11.62%	0.87%	-	-
Buyback Yield / Dilution	-2.02%	-2.05%	-35.00%	-828.01%	-	-
Total Shareholder Return	-2.02%	-2.05%	-35.00%	-828.01%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).